• Skip to main content
  • Skip to secondary menu
  • Skip to footer
Clinical Digital Resource Collaborative

Clinical Digital Resource Collaborative

Designed and developed in the North East and North Cumbria by local GPs

National Health Service
  • Home
  • About Us
  • Our Team
  • What We Offer
    • Primary Care
    • Commercial
  • Resources
    • Referral Forms
    • EMIS Resources
      • CDRC EMIS Access
      • EMIS: Long Term Condition (LTC) Management
      • Medicine Management
        • EMIS: Precision Monitoring Template
        • EMIS: DMARDs and High Risk Drugs
        • EMIS: Safe Prescribing of Opioids / Opiates
      • Specialties
        • EMIS: Cancer
        • EMIS Cardiovascular Overview
          • EMIS: Cardiovascular Disease (AF, CHD, HF, Hypertension)
          • EMIS: Cardiovascular Disease (CVD) Prevention
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Guide for EMIS
          • EMIS: Peripheral Arterial Disease Guide
        • EMIS Diabetes Overview
          • EMIS Diabetes
          • EMIS: Diabetes Technology
        • EMIS: Care for Frail Patients
        • EMIS: Haematology
        • Infection
          • EMIS: Infections Guide
          • EMIS: Blood Borne Virus (BBV)
        • EMIS: Learning Disabilities
        • EMIS: Neurology Guide
        • EMIS: NHS Health Checks
        • EMIS: Paediatric Assessment
        • EMIS: Palliative Care and End of Life
        • EMIS Renal Overview
          • Chronic Kidney Disease (CKD) – EMIS
        • Respiratory Overview
          • EMIS Respiratory Resources
          • BeatAsthma+ Guide for EMIS
        • EMIS: Rheumatology
    • SystmOne Resources
      • National Early Warning Score 2 (NEWS2) Guide for SystmOne
      • Getting Started
        • Getting Started – Access
        • Getting Started – How-To’s
      • SystmOne Administration
      • Contract Management
        • Impact and Investment Fund (IIF)
        • Quality and Outcomes Framework (QOF) Guidance for 2023/24
        • SystmOne: NHS Health Checks
        • SystmOne: WorkWell Local Enhanced Service
      • Long Term Condition Management
        • Call/ Recall System
        • Recall Recovery System
        • Care Planning
      • SystmOne Safeguarding System
        • Safeguarding Adults
        • Safeguarding At Risk of Harming Others
        • Safeguarding Family/Household Cause for Concern
        • Safeguarding Children
      • Medicine Management
        • Drugs Requiring Monitoring System
        • SystmOne: Antibiotics Prescribing & Optimisation
        • Safety & Reviews
        • Safe Prescribing of Opioids / Opiates
        • Safe Prescribing of NSAIDS
        • Safe Prescribing of Lithium
        • Safe Prescribing of Valproate
        • Safe Prescribing of Corticosteroids / Steroids
      • Specialties
        • Blood Borne Virus (BBV) Test Alert for SystmOne
        • BeatAsthma+ Guide for SystmOne
        • Cancer Overview
          • Cancer
          • Suspected Cancer
        • Cardiovascular Overview
          • Cardiology Results
          • Hypertension & Blood Pressure
          • SystmOne Heart Failure
          • Atrial Fibrillation (AF)
          • Integrated CVD Prevention
          • Peripheral Arterial Disease (PAD)
        • SystmOne Diabetes Overview
          • SystmOne Diabetes
          • SystmOne: Diabetes Technology
          • SystmOne Diabetic Kidney Disease
        • ENT Infections
        • Geriatrics Overview
          • SystmOne: Care for Frail Patients
          • Comprehensive Geriatric Assessment
          • Co-ordinated Care
        • Haematology
        • Infection Overview
        • Learning Disabilities
        • Lifestyle
        • Lipids, Familial Hypercholesterolaemia, PCSK9i & Inclisiran Overview
          • Lipids, Familial Hypercholesterolaemia (FH), PCSK9i & Inclisiran Report Guide for SystmOne
          • Lipids Protocols
          • Lipid Management Templates
          • Lipid QoF Support
          • Screening for Familial Hypercholesterolaemia
          • Aetiology of Abnormal Lipids
          • Lipids Strategy
        • MSK Referral Management
        • Neurology
        • Obesity Resources
        • Ophthalmology
        • Palliative Care and End of Life
        • SystmOne Renal/Urology Overview
          • Chronic Kidney Disease (CKD)
        • Respiratory Overview
          • Respiratory Resources
          • Respiratory Infections
        • Rheumatology Overview
          • SystmOne: Osteoporosis and Fragility Fractures
          • Bone Health
      • SystmOne: Weight Management
      • Women’s Health Overview
        • Gynaecology Resource Overview
          • Cervical Screening
          • Contraception
          • Prolapse
        • 6-8 Week Postnatal Check
      • Vaccination Overview
        • COVID-19 Resources- SystmOne
        • Influenza Vaccination SystmOne
        • Meningitis B Vaccination
        • Meningitis ACWY Vaccination
        • Pneumococcal Vaccination
        • RSV Vaccination SystmOne
        • Shingles Vaccination
  • FAQs
  • News and Events
    • Demonstrations
    • Events
      • Recordings
    • Articles
    • Conference abstracts
  • Contact us
You are here: Home / News / Changes to the ‘COPD Register’ QoF Code Cluster in SystmOne

Changes to the ‘COPD Register’ QoF Code Cluster in SystmOne

30 June 2026

There have been some recent updates made to the COPD QoF business rules which affect how the COPD QoF register is defined.

Key changes include:

  1. Changes to diagnostic coding inclusion
    Some codes that were previously included in the COPD register are no longer counted. Examples include:
    • Exacerbation of COPD codes
    • Chronic bronchitis codes
    • Some emphysema codes
  2. Newly included codes
    Two additional codes are now included:
    • COPD causing sleep disturbance
    • COPD not causing sleep disturbance
  3. Inclusion based on process codes
    Patients will now be added to the COPD QoF register if certain COPD-related process codes have been recorded within the last two years. These include:
    • Selected COPD review codes (e.g. COPD annual review)
    • Selected COPD review invitation codes (e.g. COPD monitoring invitation)

These changes mean that the composition of the COPD QoF register may shift, with some patients no longer included and others being newly identified based on the updated criteria.

We have engaged with NHS England to seek clarification and have provided feedback on these changes; however, they will remain in place despite the concerns raised.

To support practices in managing this transition, CDRC have developed the following resources:

1. CDRC COPD Alerts and Recalls

From 1 August 2026, CDRC functions (including LTC recall systems and quality control/safety reports) will align with the updated QoF COPD diagnosis codes as the basis for the CDRC COPD register.

Patients included solely due to process codes (e.g. review codes) will not be classified as having COPD within the CDRC register.

To ensure consistency and data quality, it is recommended that the following quality control searches are completed before the end of July.

2. CDRC Quality Control Reports

The following reports are available on SystmOne within the CDRC Quality > Respiratory Folder

here have been some unusual changes to the COPD QoF business rules affecting the COPD QoF register.

* The most sensible code to use is Chronic obstructive pulmonary disease 13645005 (CTV H3)

The COPD Diagnosis visualisation can support this review process by bringing together key clinical information from the patient record, including spirometry results and relevant diagnostic and activity codes.

The example below shows a patient who was previously included on the COPD register due to a chronic bronchitis code. Under the updated rules, the patient now appears on the register only because a COPD review or invitation has been recorded within the last two years. In such cases, this patient will be removed from the register if further reviews or invitations are not recorded.

3.  Coding Protocols

Two new automatic protocols are available to help prevent inappropriate coding:

  1. Legacy Diagnosis Code Alert
    1. A protocol to alert the user when a legacy COPD diagnosis code (e.g exacerbation of COPD) is entered for a patient who does not have a COPD diagnosis code included in the updated QoF list.
  2. Review/Invitation Code Alert
    1. A protocol to alert the user when a COPD review / invitation code (e.g COPD annual review) is recorded for a patient who does not have a COPD diagnostic code in the updated QoF list.

To activate these protocols, you must have CDRC Respiratory resources activated.  You can check this by running the Customisation – Respiratory – Units Activated report. If this report returns a number similar to your practice list size, the resources are activated. 

If you would like them activated contact contact-cdrc@healthinnovationnenc.org.uk

Thank you

CDRC

Filed Under: News

Footer

Follow us on social media

  • Facebook
  • LinkedIn
  • Twitter
contact-cdrc@healthinnovationnenc.org.uk
This website is operated by Health Innovation North East and North Cumbria. Suite A, 2nd Floor, 1 Citygate, Gallowgate, Newcastle upon Tyne NE1 4WH. Registered in England and Wales, Company Registration Number: 08727658
  • Terms of Reference
  • Privacy policy
  • Terms of use
  • Cookie Policy (UK)
  • Accessibility Statement

Copyright © 2026 Clinical Digital Resource Collaborative

Manage Consent
We use cookies to optimise our website and our service.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}